Webinar | On demand

Orphan Drugs: Are They Losing Their Sparkle?

For ten years, orphan drugs have doubled their market share in global prescription drug sales, surpassing non-orphan drugs. However, their once bright gloss is beginning to dull, and their growth advantage is diminishing. Sign up for our webinar to discover the reasons behind this shift and what the future may hold.

Watch the webinar.

I would like to receive Evaluate industry & market reports, and the latest news from Evaluate.

Your information will be used in accordance with our Privacy notice.

What to Expect

Get expert insights on:

Major players in the field
Exciting therapy areas
Technologies primed to drive growth
Rare diseases’ significance for big pharma
What’s piquing investors’ interest?
The impact of new legislation on R&D pipelines

Watch our to discover the reasons behind this shift and what the future may hold.

Webinar | On demand

Orphan Drugs: Are They Losing Their Sparkle?

Watch the webinar.

What to Expect

Melanie Senior

Author, Orphan Drug Report

Stephanie Léouzon

Managing Director, Biopharma Healthcare, Stifel

Puru Gaur

Senior Commercial Analyst, Evaluate

Copyright © 2024 Evaluate, a Norstella Company